P

Inventor

WU DEDONG

US13 patents
⚠️ This page may combine multiple inventors who share the name “WU DEDONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ASTRAZENECA AB

9 patents
US12195485B2Jan 14, 2025

Arginase inhibitors and methods of use thereof

ASTRAZENECA AB4 citations83
US11912727B2Feb 27, 2024

Arginase inhibitors and methods of use thereof

ASTRAZENECA AB4 citations83
US11420984B2Aug 23, 2022

Arginase inhibitors and methods of use thereof

ASTRAZENECA AB7 citations83
US9840518B2Dec 12, 2017

MCL-1 inhibitors and methods of use thereof

ASTRAZENECA AB9 citations81
US11952392B2Apr 9, 2024

Arginase inhibitors and methods of use thereof

ASTRAZENECA AB2 citations71
US10889594B2Jan 12, 2021

MCL-1 inhibitors and methods of use thereof

ASTRAZENECA AB0 citations60
US11472816B2Oct 18, 2022

Mcl-1 inhibitors and methods of use thereof

ASTRAZENECA AB0 citations58
US10196404B2Feb 5, 2019

MCL-1 inhibitors and methods of use thereof

ASTRAZENECA AB0 citations47
US10149839B2Dec 11, 2018

Chemical compounds

ASTRAZENECA AB0 citations47

WU DEDONG

1 patent
US11345697B1May 31, 2022

Crystalline berberine ascorbate salt, methods of preparation and applications thereof

WU DEDONG5 citations67

DIZAL JIANGSU PHARMACEUTICAL CO LTD

1 patent
US12319670B2Jun 3, 2025

Compounds and methods for inhibiting JAK

DIZAL JIANGSU PHARMACEUTICAL CO LTD0 citations57

JIANGXI FUSHINE PHARMACEUTICAL CO LTD

1 patent
US10577379B1Mar 3, 2020

Fenofibric acid salt with berberine or its analogues, crystalline forms, methods of preparation, and applications thereof

JIANGXI FUSHINE PHARMACEUTICAL CO LTD3 citations57

LONGEVITAN BIOSCIENCES LLC

1 patent
US12358922B1Jul 15, 2025

Berberine alpha-ketoglutarate salt, crystalline form, methods of preparation and applications thereof

LONGEVITAN BIOSCIENCES LLC0 citations42